CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 10 enrolled
Drug / intervention
Continuous Glucose Monitor (CGM)device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02572856
NCT02572856N/ACompleted
CompareCT.gov

Continuous Glucose Monitoring During and After Surgery

University of Washington·interventional·Posted Oct 9, 2015·Updated Aug 31, 2023

In Brief

A clinical study evaluating Continuous Glucose Monitor (CGM) for Diabetes. Completed, enrolled 10 participants across 1 site.

Detailed Summary

During surgery and after surgery elevated blood glucose levels can lead to poor outcome such as wound infections. Current technology does not allow close monitoring of glucose levels often resulting in poor management of glucose levels. In this study, the investigators will evaluate the feasibility of using a continuous glucose monitor (Dexcom Gen 6 Professional) during and after surgery. Such a monitor has the potential of monitoring glucose levels continuously and in real-time, thus allowing better glucose management

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetes
CountriesUnited States
CollaboratorsDexCom, Inc.

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedOct 9, 2015
Enrollment StartAug 1, 2018
Primary CompletionMay 31, 2019
Study CompletionNov 16, 2021
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 10.7 years ago

Interventions

Continuous Glucose Monitor (CGM)device

Apply Dexcom Gen 6 Professional CGM sensor at least 2.5 hours prior to surgery Configure CGM so that its measurements are blinded. Setup CGM to make continuous glucose measurements during and after surgery. Download CGM measurement data after study and compare measurements against glucose measurements made for clinical care.